Immutep Ltd Files Form 6-K
Ticker: PRRUF · Form: 6-K · Filed: Dec 17, 2024 · CIK: 1506184
| Field | Detail |
|---|---|
| Company | Immutep Ltd (PRRUF) |
| Form Type | 6-K |
| Filed Date | Dec 17, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
Related Tickers: IMMU
TL;DR
Immutep (IMMU) filed a 6-K, standard foreign issuer report.
AI Summary
Immutep Limited, formerly Prima BioMed Ltd, filed a Form 6-K on December 17, 2024. The company, based in Sydney, Australia, operates in the Pharmaceutical Preparations sector. This filing is a report of a foreign private issuer.
Why It Matters
This filing indicates Immutep is a foreign private issuer and provides standard corporate information, which is important for investors tracking regulatory disclosures.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of corporate information for a foreign private issuer and does not contain material new financial or operational information.
Key Players & Entities
- IMMUTEP Ltd (company) — Registrant
- Prima BioMed Ltd (company) — Former company name
- 20241217 (date) — Filing date
- 001-35428 (other) — Commission File Number
FAQ
What is the primary purpose of a Form 6-K filing?
A Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to submit information required to be made public in the issuer's home country or filed with a stock exchange.
What is Immutep Limited's former company name?
Immutep Limited's former company name was Prima BioMed Ltd.
Where is Immutep Limited's principal executive office located?
Immutep Limited's principal executive office is located at Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.
What is Immutep Limited's standard industrial classification?
Immutep Limited's standard industrial classification is Pharmaceutical Preparations [2834].
On what date was this Form 6-K filed?
This Form 6-K was filed on December 17, 2024.
Filing Stats: 255 words · 1 min read · ~1 pages · Grade level 16.9 · Accepted 2024-12-17 14:39:58
Filing Documents
- d809004d6k.htm (6-K) — 9KB
- d809004dex991.htm (EX-99.1) — 14KB
- g809004g30z01.jpg (GRAPHIC) — 7KB
- 0001193125-24-280370.txt ( ) — 35KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: December 17, 2024 IMMUTEP LIMITED By: /s/ Marc Voigt Name: Marc Voigt Title: Chief Executive Officer